These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 23706679

  • 1. [New oral anticoagulants and digestive hemorrhages].
    Diallo I, Mallaret C, Jourdan S, Brardjanian S, Guisset M, Coton T.
    Presse Med; 2014 Jan; 43(1):85-7. PubMed ID: 23706679
    [No Abstract] [Full Text] [Related]

  • 2. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS, Singh S, Alexander GC, Heien H, Haas LR, Crown W, Shah ND.
    BMJ; 2015 Apr 24; 350():h1857. PubMed ID: 25910928
    [Abstract] [Full Text] [Related]

  • 3. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.
    Baumann Kreuziger LM, Reding MT.
    Thromb Res; 2013 Aug 24; 132(2):e161-3. PubMed ID: 23916381
    [No Abstract] [Full Text] [Related]

  • 4. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
    Chang HY, Zhou M, Tang W, Alexander GC, Singh S.
    BMJ; 2015 Apr 24; 350():h1585. PubMed ID: 25911526
    [Abstract] [Full Text] [Related]

  • 5. Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
    Sherid M, Sifuentes H, Sulaiman S, Samo S, Husein H, Tupper R, Thiruvaiyaru D, Spurr C, Sridhar S.
    Digestion; 2014 Apr 24; 90(2):137-46. PubMed ID: 25278002
    [Abstract] [Full Text] [Related]

  • 6. New approaches to reversing oral anticoagulant therapy. Introduction.
    Nutescu EA.
    Am J Health Syst Pharm; 2013 May 15; 70(10 Suppl 1):S1-2. PubMed ID: 23640527
    [No Abstract] [Full Text] [Related]

  • 7. Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery.
    Chang TW, Arpey CJ, Baum CL, Brewer JD, Hochwalt PC, Hocker TL, Roenigk RK, Otley CC.
    Dermatol Surg; 2015 Jul 15; 41(7):784-93. PubMed ID: 26057410
    [Abstract] [Full Text] [Related]

  • 8. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.
    Kardiol Pol; 2012 Jul 15; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract] [Full Text] [Related]

  • 9. Emergency surgery and trauma in patients treated with the new oral anticoagulants: dabigatran, rivaroxaban, and apixaban.
    Moorman ML, Nash JE, Stabi KL.
    J Trauma Acute Care Surg; 2014 Sep 15; 77(3):486-94; quiz 486-94. PubMed ID: 25159255
    [No Abstract] [Full Text] [Related]

  • 10. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
    Páramo JA.
    Med Clin (Barc); 2013 Oct 19; 141(8):346-8. PubMed ID: 23831406
    [No Abstract] [Full Text] [Related]

  • 11. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep 19; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 12. Safety of new oral anticoagulants.
    Vaughan Sarrazin MS, Rose A.
    BMJ; 2015 Apr 24; 350():h1679. PubMed ID: 25911527
    [No Abstract] [Full Text] [Related]

  • 13. Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.
    Desai J, Kolb JM, Weitz JI, Aisenberg J.
    Thromb Haemost; 2013 Aug 24; 110(2):205-12. PubMed ID: 23702623
    [No Abstract] [Full Text] [Related]

  • 14. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.
    Fawole A, Daw HA, Crowther MA.
    Cleve Clin J Med; 2013 Jul 24; 80(7):443-51. PubMed ID: 23821689
    [Abstract] [Full Text] [Related]

  • 15. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 16. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
    Chan KE, Edelman ER, Wenger JB, Thadhani RI, Maddux FW.
    Circulation; 2015 Mar 17; 131(11):972-9. PubMed ID: 25595139
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
    Gorzelak-Pabiś P, Duraj I, Szlagowska L, Ciastkowska A, Broncel M.
    Pol Merkur Lekarski; 2014 Nov 17; 37(221):261-4. PubMed ID: 25546985
    [Abstract] [Full Text] [Related]

  • 18. Effective antidotes for new anticoagulants.
    Lythgoe M.
    BMJ; 2015 May 26; 350():h2775. PubMed ID: 26014356
    [No Abstract] [Full Text] [Related]

  • 19. Management of hemorrhage complicated by novel oral anticoagulants in the emergency department: case report from the northwestern emergency medicine residency.
    Kiraly A, Lyden A, Periyanayagam U, Chan J, Pang PS.
    Am J Ther; 2013 May 26; 20(3):300-6. PubMed ID: 23584314
    [Abstract] [Full Text] [Related]

  • 20. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun 26; 22(139):155-9. PubMed ID: 23866358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.